Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
|
In Today's Vidyya A new chemotherapeutic regimen extends the survival rate for colorectal cancer patients. |
|
Screening For Colorectal Cancer - Information For Health Professionals Screening for colorectal cancer is recommended for all persons aged 50 and older with annual fecal occult blood testing (FOBT), or sigmoidoscopy or both. More... |
|
Revised Breast Cancer Treatment Guidelines For Patients Now Available Breast cancer patients now have a more comprehensive resource in their fight against cancer, thanks to the commitment of the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS). Version III of the NCCN Breast Cancer Treatment Guidelines for Patients is now available. Originally launched in March 1999, this well-received resource for breast cancer patients has been updated to reflect changes to the current NCCN Breast Cancer Guidelines. More... |
|
New Colorectal Chemotherapy Regimen Improves Patient Survival Rates
A new chemotherapy regimen prolongs survival rates for patients with metastatic (advanced) colorectal cancer, according to an international study published today in The New England Journal of Medicine. More... |
|
Prescribing Information - Camptosar Camptosar (irinotecan hydrochloride) is a relatively new drug that exhibits antineoplastic properties against certain types of colorectal carcinoma. Get the complete prescribing information and read the instructions for the safe handling of chemotherapeutic agents in this package insert. More... |
|
FDA Approves Arsenic Trioxide For Leukemia Treatment In Record Time The FDA has approved Trisenox (arsenic trioxide) for the treatment of patients with acute promyelocytic leukemia (APL) who have not responded to, or have relapsed following the use of all trans-retinoic acid and anthracycline-based chemotherapy, which is considered first line therapy. More... |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.